STON2 and metastatic malignant neoplasm in the lymph nodes: In contrast, STON2 expression had no correlation with patient age; histological type; FIGO stage; differentiation grade; lymph node metastasis; serum CA125, CA199, CEA, NSE, and β-HCG levels; and other clinicopathological features (Table 3).